Post-ischemic inflammation and therapeutic strategyc
文献类型：期刊论文
| 作者 | WANG Zhifei; TANG Xican
|
| 刊名 | Chinese Journal of New Drugs and Clinical Remedies
 |
| 出版日期 | 2007 |
| 卷号 | 26期号:6页码:454-461 |
| 关键词 | brain ischemia injuries inflammation j therapeutic strategies |
| ISSN号 | 1007-7669 |
| 其他题名 | 脑缺血损伤的炎症反应及治疗策略展望 |
| 文献子类 | Article |
| 英文摘要 | Studies show that inflammation plays an important role in cerebral ischemic injury.Post- ischemic inflammation is a dynamic process involving a complicated set of interactions among various inflammatory cells and molecules.It is a consequence of infiltration of peripheral inflammatory cells into the brain and activation of glial cells and resident macrophages.Inflammation contributes to the late stages of ischemic injury,alleviates neuronal survival and results in worsening of neurologic outcome.Studies on the mechanism of post-ischemic inflammation are yielding insight into therapeutic strategies for ischemic stroke.This review focuses on the main inflammatory cells and proinflammatory factors involved in the post-ischemic inflammation,as well as the promising therapeutic strategies. |
| 资助项目 | 国家自然科学基金[00000000] |
| WOS研究方向 | Neurosciences & Neurology (provided by Clarivate Analytics) |
| 语种 | 中文 |
| CSCD记录号 | CSCD:2822762 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/268114]  |
| 专题 | 药物化学研究室 |
| 作者单位 | State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of, Sciences, SHANGHAI 201203, China. |
| 推荐引用方式 GB/T 7714 | WANG Zhifei,TANG Xican. Post-ischemic inflammation and therapeutic strategyc[J]. Chinese Journal of New Drugs and Clinical Remedies,2007,26(6):454-461. |
| APA | WANG Zhifei,&TANG Xican.(2007).Post-ischemic inflammation and therapeutic strategyc.Chinese Journal of New Drugs and Clinical Remedies,26(6),454-461. |
| MLA | WANG Zhifei,et al."Post-ischemic inflammation and therapeutic strategyc".Chinese Journal of New Drugs and Clinical Remedies 26.6(2007):454-461. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。